
19 Jul 2024
Debunking Myths: Type 2 Diabetes & Fruits
Living with type 2 diabetes often comes with a host of dietary restrictions and myths that can make managing the condition […]

Blog / Article
5 Aug 2026
Vitamin K2 and bone health have been linked in research for years, yet most people have never heard of K2. They know vitamin K exists, usually from a doctor mentioning leafy greens and blood thinners, but K2 is a different story entirely. As a dietitian, I find it one of the most under appreciated nutrients in bone and cardiovascular health, and the research behind it is quietly becoming very hard to ignore.
Vitamin K2 isn’t about blood clotting the way K1 is. Its main job in the body is directing calcium to where it belongs. It activates a protein called osteocalcin, which binds calcium to bone tissue and supports bone mineralization.
Without enough K2, this process becomes less efficient. Osteocalcin stays underactivated, calcium doesn’t bind properly, and bone density can suffer over time. This is particularly relevant for postmenopausal women, who experience accelerated bone loss due to declining estrogen.
A recent study reviewed multiple randomized controlled trials and found that K2 supplementation significantly improved bone turnover markers in postmenopausal women with osteoporosis. Earlier research involving 240 healthy postmenopausal women found that three years of K2 supplementation measurably increased markers of active bone formation compared to placebo.
Here’s where it gets particularly interesting. The same mechanism that directs calcium into bones also prevents it from depositing somewhere it doesn’t belong, the arteries.
K2 activates another protein called Matrix Gla Protein (MGP), which acts as a natural inhibitor of arterial calcification. When K2 levels are low, MGP stays inactive and calcium can accumulate in artery walls. Over time, this contributes to arterial stiffness and a higher risk of cardiovascular disease.
Recent research from the VitaK-CAC Trial found that two years of K2 supplementation slowed the progression of coronary artery calcification by 22% in people with mild-to-moderate coronary artery disease. Separate research found that K2 supplementation reduced vascular stiffness and improved blood pressure in postmenopausal women with low K2 status, the first study to confirm this particular benefit.
This dual role, building bones while protecting arteries, is what makes K2 genuinely stand out among nutrients.
Vitamin K1 (phylloquinone) and vitamin K2 (menaquinone) share a similar basic structure but behave quite differently in the body. K1 is absorbed quickly, gets used by the liver for clotting factor production, and clears from the bloodstream fast. K2 stays in circulation longer, reaching bone and arterial tissue in ways K1 simply doesn’t.
This is why eating plenty of leafy greens (a rich source of K1) doesn’t necessarily mean K2 levels are adequate. They serve different functions, and K2 needs to come from its own dietary sources or supplementation.
Within K2 itself, MK-7 (the form found in fermented foods like natto) has a longer half-life in the body than MK-4, making it the more researched and bioavailable form for bone and cardiovascular benefits.
K2 isn’t as easy to find in the diet as K1. The richest sources include:
Fermentation is the key pattern here. Bacteria produce K2, which is why fermented and animal-based foods dominate this list. For people who don’t eat many of these foods regularly, dietary intake may fall short of what research suggests is beneficial.
Supplementation is worth discussing with a healthcare provider, particularly for postmenopausal women, those with osteoporosis risk factors, or anyone with cardiovascular concerns. The most studied supplemental form is MK-7, typically in doses ranging from 90 to 200 micrograms daily.
One important note: if you take warfarin or other anticoagulant medications, talk to your doctor before starting K2. It doesn’t interact the same way K1 does, but any change in vitamin K intake is worth flagging with whoever manages your medication.
Vitamin K2 also works well alongside vitamin D3, since both support calcium metabolism and complement each other’s roles in bone and cardiovascular health. Many practitioners recommend taking them together for this reason.
The evidence for vitamin K2 and bone health, and for its cardiovascular role, is growing and increasingly well-supported. That said, most studies are still relatively short-term or focused on specific populations like postmenopausal women. Larger, longer trials across broader age groups and health statuses would strengthen the picture further.
What we can say with confidence is that K2 is a nutrient most people aren’t getting enough of, and the research supporting its role in both bone and heart health is now substantial enough to take seriously.
Given how underappreciated it is, yes. Vitamin K2 and bone health represent one of the clearest examples of a nutrient whose benefits go well beyond what most people expect. Add the arterial calcification research into the picture, and K2 starts to look like one of the more compelling nutritional stories of the last decade.
Getting more through food is always a good first step. For many people, a quality MK-7 supplement fills the gap that diet alone may not. Either way, it’s a conversation worth having with your dietitian or healthcare provider.